0001447348-16-000060.txt : 20160422 0001447348-16-000060.hdr.sgml : 20160422 20160422170942 ACCESSION NUMBER: 0001447348-16-000060 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101201 FILED AS OF DATE: 20160422 DATE AS OF CHANGE: 20160422 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MADDON PAUL J CENTRAL INDEX KEY: 0001250313 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 161587246 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591 4/A 1 edgardoc.xml PRIMARY DOCUMENT X0306 4/A 2010-12-01 2010-12-01 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001250313 MADDON PAUL J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2010-12-01 4 P 0 5000 4.9 A 909891 D Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. This transaction was executed in multiple trades at prices ranging from $4.85 to $4.98. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This report amends the report filed on December 1, 2010 in order to correct an administrative error in the issuer's records as to the number of shares beneficially owned by the reporting person reported in Column 5 of Table I. /s/ Paul J. Maddon 2016-04-22